INSIGHTS ON DRUG DEVELOPMENT
-
mTOR Pathway
Explore the mTOR signaling pathway and reveal how mTORC1 regulates cell growth, metabolism, and survival to ensure cellular function and adaptation to environmental cues.
-
Five Practical Considerations To Move From Concept To Clinic
Learn more about five key factors for advancing targeted in vivo LNP programs, from formulation and targeting strategies to bioanalytical readiness and scalability.
-
5 Key Considerations For Companies Outsourcing Process Development
Venture capital in biotech remains strong post-pandemic, especially in cell and gene therapies. Discover five key factors to help companies choose between in-house and outsourced process development strategies.
-
Complete Your Journey To Therapeutic Success
Explore integrated workflows for peptide identification, impurity analysis, sequence confirmation, and characterization, supported by advanced technology and expert guidance to improve productivity.
-
Ask Us Anything: Matt Bio On Peptide Commercialization Trends7/23/2026
Matt Bio, CSO of Cambrex and President of Snapdragon Chemistry, on the capacity bottleneck behind peptide shortages — and why moving from solid-phase to liquid-phase synthesis unlocks reactors already sitting idle around the world.
-
Get More From Less: AMP Chemistry Outperforms Hybrid Capture6/9/2026
Sequencing performance can drop quickly with low-quality, low-input FFPE DNA. Gain insight into how one approach helps labs minimize repeats and maintain more consistent results.
-
Use Of Spray Drying In Pharmaceutical Product Development10/21/2024
Through this detailed exploration, participants will gain valuable knowledge on how to leverage spray drying to optimize drug development and delivery.
-
Direct qPCR Amplification From Human Urine Samples6/9/2026
Extraction-free qPCR enables faster, lower-cost detection of UTI-associated bacteria directly from urine samples. Explore how this approach simplifies workflows and accelerates time to results.
-
Ask Us Anything: David Ford On AI And Automation Trends7/23/2026
David Ford, Senior Director of Chemistry at Snapdragon Chemistry, on the mountain of data behind every process development program — and why AI's real promise is surfacing the right piece of it at the moment a team needs to decide.
DRUG DEVELOPMENT SOLUTIONS
-
Review three of our key compounds — Testosterone Base, Testosterone Cypionate, and Testosterone Propionate — each presented with essential identifiers such as CAS numbers, structural features, and typical marketed dosage forms.
-
We offer mRNA drug substance, formulated bulk drug product manufacturing (encapsulation), and fill/finish from a single site.
-
Enhance therapeutic success by optimizing N-glycan profiles with titratable formulations tailored to meet your bioproduction needs.
-
Orbis provides innovative taste-making and controlled release solutions for oral and injectable pharmaceutical products.
-
The iCELLis™ bioreactor system is an automated, single-use, fixed-bed bioreactor that provides excellent cell growth conditions for adherent cells.